Investigative and Clinical Urology

The Korean Urological Association (대한비뇨의학회)
권호 표지
DOI QR코드

DOI QR Code

Preoperative Erythropoietin Administration in Patients With Prostate Cancer Undergoing Radical Prostatectomy Without Transfusion

  • Lee, Byung Woo (Department of Urology, Inje University Seoul Paik Hospital) ;
  • Park, Min Gu (Department of Urology, Inje University Seoul Paik Hospital) ;
  • Cho, Dae Yeon (Department of Urology, Inje University Seoul Paik Hospital) ;
  • Park, Seok San (Department of Urology, Inje University Seoul Paik Hospital) ;
  • Yeo, Jeong Kyun (Department of Urology, Inje University Seoul Paik Hospital)
  • Received : 2013.06.18
  • Accepted : 2013.10.08
  • Published : 2014.02.22
⟨ Previous Next ⟩

Abstract

Purpose: In this study, we administered erythropoietin preoperatively to patients who underwent open radical prostatectomy without transfusion to increase their hemoglobin levels and investigated the efficacy of this procedure. Materials and Methods: We evaluated 62 patients who underwent open radical prostatectomy performed by the same surgeon between June 2005 and January 2011. The 22 patients who refused transfusion were assigned to group 1; the patients who accepted transfusion were assigned to group 2. Before surgery, we administered erythropoietin beta to group 1 patients whose hemoglobin levels were <12 g/dL and retrospectively compared the clinical data of the two groups. We used the t-test and the chi-square test for statistical analysis. Results: Mean preoperative hemoglobin levels in group 1 after erythropoietin administration (14.5 g/dL) were significantly higher than those in group 2 (13.59 g/dL, p=0.003). Moreover, the difference in the mean hemoglobin levels before and after surgery for group 1 patients (3.55 g/dL) significantly exceeded that for group 2 patients (2.08 g/dL, p=0.000). Additional analysis revealed no statistically significant differences in perioperative complications between the groups. Conclusions: Preoperative erythropoietin administration increased the safety margin of hemoglobin levels, and this strategy worked sufficiently well in our experience.

Keywords

References

  1. Lloyd JC, Banez LL, Aronson WJ, Terris MK, Presti JC Jr, Amling CL, et al. Preoperative predictors of blood loss at the time of radical prostatectomy: results from the SEARCH database. Prostate Cancer Prostatic Dis 2009;12:264-8. https://doi.org/10.1038/pcan.2009.6
  2. Gohel MS, Bulbulia RA, Slim FJ, Poskitt KR, Whyman MR. How to approach major surgery where patients refuse blood transfusion (including Jehovah's Witnesses). Ann R Coll Surg Engl 2005;87:3-14.
  3. Wurnig C, Schatz K, Noske H, Hemon Y, Dahlberg G, Josefsson G, et al. Subcutaneous low-dose epoetin beta for the avoidance of transfusion in patients scheduled for elective surgery not eligible for autologous blood donation. Eur Surg Res 2001;33:303-10. https://doi.org/10.1159/000049723
  4. Burnett AL, Allaf ME, Bivalacqua TJ. Erythropoietin promotes erection recovery after nerve-sparing radical retropubic prostatectomy: a retrospective analysis. J Sex Med 2008;5:2392-8. https://doi.org/10.1111/j.1743-6109.2008.00980.x
  5. van Haelst IM, Egberts AC, Doodeman HJ, van Solinge WW, Kalkman CJ, Bennis M, et al. Occurrence and determinants of poor response to short-term pre-operative erythropoietin treatment. Acta Anaesthesiol Scand 2013;57:350-7. https://doi.org/10.1111/aas.12029
  6. Shander A. Acute normovolaemic hemodilution (ANH). A practical approach. TATM 1999;1:7-10.
  7. Tulloh BR, Brakespear CP, Bates SC, Adams DC, Dalton RG, Richards MJ, et al. Autologous predonation, haemodilution and intraoperative blood salvage in elective abdominal aortic aneurysm repair. Br J Surg 1993;80:313-5. https://doi.org/10.1002/bjs.1800800314
  8. Eschwege P, Dumas F, Benoit G, Loric S. Autologous blood transfusion as a potential source of prostate cancer cells spread during radical prostatectomy. Prostate Cancer Prostatic Dis 1999;2(S3):S13. https://doi.org/10.1038/sj.pcan.4500339
  9. Gray CL, Amling CL, Polston GR, Powell CR, Kane CJ. Intraoperative cell salvage in radical retropubic prostatectomy. Urology 2001;58:740-5. https://doi.org/10.1016/S0090-4295(01)01365-6
  10. Crescenti A, Borghi G, Bignami E, Bertarelli G, Landoni G, Casiraghi GM, et al. Intraoperative use of tranexamic acid to reduce transfusion rate in patients undergoing radical retropubic prostatectomy: double blind, randomised, placebo controlled trial. BMJ 2011;343:d5701. https://doi.org/10.1136/bmj.d5701
  11. McLoughlin PL, Cope TM, Harrison JC. Hyperbaric oxygen therapy in the management of severe acute anaemia in a Jehovah's witness. Anaesthesia 1999;54:891-5. https://doi.org/10.1046/j.1365-2044.1999.01004.x
  12. Atabek U, Alvarez R, Pello MJ, Alexander JB, Camishion RC, Curry C, et al. Erythropoetin accelerates hematocrit recovery in post-surgical anemia. Am Surg 1995;61:74-7.

Cited by

  1. Impact of Peri-Operative Anemia and Blood Transfusions in Patients with Gastric Cancer Receiving Gastrectomy vol.17, pp.3, 2016, https://doi.org/10.7314/apjcp.2016.17.3.1427
  2. COMPLEX PANCREATIC RESSECTIONS WITH VASCULAR INVOLVEMENT IN JEHOVAH'S WITNESSES: HOW TO APPROACH? vol.29, pp.4, 2016, https://doi.org/10.1590/0102-6720201600040019
  3. Does Postoperative Erythropoietin Reduce Transfusions and Hemodynamic Instability Following Liposuction, Either Alone or Associated with Abdominoplasty or Mammaplasty? A Comparative, Prospective Study vol.41, pp.1, 2014, https://doi.org/10.1007/s00266-016-0748-0
  4. Holmium laser enucleation of the prostate in Jehovah’s Witness patients vol.52, pp.3, 2014, https://doi.org/10.1007/s11255-019-02331-x